FHL-301
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FHL-301, covering 2025-10-15 to 2025-10-15. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety, Tolerability, Efficacy, and PK of FHL-301 in Parkinson's Disease Patients. [Phase 2]